Results 71 to 80 of about 6,394 (171)
IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway
Blood–retinal barrier (BRB) dysfunction underlies macular oedema in many sight-threatening conditions, including diabetic macular oedema, neovascular age-related macular degeneration and uveoretinitis.
Eimear M. Byrne +5 more
doaj +1 more source
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. [PDF]
BACKGROUND: Proliferative diabetic retinopathy (PDR) is a complication of diabetic retinopathy that can cause blindness. Although panretinal photocoagulation (PRP) is the treatment of choice for PDR, it has secondary effects that can affect vision.
Buil-Calvo, José A +6 more
core +2 more sources
ABSTRACT Diabetic retinopathy (DR) is a leading cause of vision impairment in patients diagnosed with Type 2 diabetes mellitus (T2DM). Awareness of risk factors is necessary to reduce or prevent harmful effects of DR such as irreversible vision loss, and to help ensure early treatment.
Yu‐Chi Sung +8 more
wiley +1 more source
Anti-VEGF Therapy and the Retina: An Update
Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring ...
Vikas Tah +7 more
doaj +1 more source
Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy? [PDF]
Aim - To briefly review and discuss the literature on why patients still require surgery for the late complications of proliferative diabetic retinopathy (PDR).\ud Methods: Literature review.\ud \ud \ud Results - The reasons for incomplete coverage of ...
Scanlon, Peter H
core +1 more source
Abstract Background Imaging of the retina is accompanied by distortions so that positions in fundus photographs cannot be linearly translated to positions in the retinal fundus. The purpose of this study was to describe an algorithm and evaluate its reproducibility in identifying points on the retina from their representation on serial fundus ...
Toke Bek, Giovanni Ometto
wiley +1 more source
Aims. To assess the association of blood oxygen-transport capacity variables with the prevalence of diabetic retinopathy (DR), retinal ischemia, and macular oedema in patients with type 2 diabetes mellitus (T2DM). Methods.
Alicia Traveset +9 more
doaj +1 more source
Integrated results from the COPERNICUS and GALILEO studies. [PDF]
OBJECTIVES: To report on the efficacy and safety of intravitreal aflibercept in patients with macular edema secondary to central retinal vein occlusion (CRVO) in an integrated analysis of COPERNICUS and GALILEO.
Ahlers, Christiane +13 more
core +3 more sources
Abstract Purpose To investigate the role of spectral domain optical coherence tomography (SD‐OCT)‐based biomarkers in predicting treatment response of macular oedema (MO) secondary to retinal vein occlusion (RVO) to anti‐vascular endothelial growth factor (VEGF) therapy.
Ken K. Tsang +9 more
wiley +1 more source
Image-processing pipeline for diagnosing diabetic macular ischaemia in diabetic macular oedema
Diabetic Macular Ischaemia (DMI) is a critical cause of vision loss, frequently occurring alongside Diabetic Macular Oedema (DMO) in patients with severe diabetic retinopathy.
Xiaofan Xiong +5 more
doaj +1 more source

